Association of angiotensin-converting enzyme (ACE) and fatty acid binding protein 2 (FABP2) genes polymorphism with type 2 diabetes mellitus in Northern India

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 4, 2014, Pages 572-579

  Raza, Syed Tasleem ^a   Fatima, Jalees ^a   Ahmed, Faisal ^a   Abbas, Shania ^a   Zaidi, Zeashan Haider ^a   Singh, Seema ^b   Mahdi, Farzana ^a  

^a Era's Lucknow Medical College and Hospital   (India)

^b INTEGRAL UNIVERSITY   (India)

Author keywords

ACE; FABP2; genetic polymorphism; genetic susceptibility; T2DM

Indexed keywords

ALANINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; FATTY ACID BINDING PROTEIN 2; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THREONINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; AGAR GEL ELECTROPHORESIS; ALLELE; CASE CONTROL STUDY; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ADULT; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, AGAR GEL; ETHNIC GROUPS; FATTY ACID-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 84918543604     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313481082     Document Type: Article

References (38)

1. Snehalatha C, Ramachnadaran A. Insight into the mechanism of primary prevention of type 2 diabetes: Improvement in insulin sensitivity and beta cell function. International Symposium on Genetic and Epigenetic Basis of Complex Diseases, Centre for Cellular and Molecular Biology ; Hyderabad, India ;..
2. Hoskote SS, Joshi SR. Are Indians destined to be diabetic?. J Assoc Physicians India. 2008 ; 56: 225-226
3. Evans TC, Capell P. Diabetic nephropathy. Clinical Diab. 2000 ; 18: 1-16
4. Ergen HA, Hatemi H, Agachan B, et al. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med. 2004 ; 36: 345-350
5. Hubert C, Houot AM, Corvol P, et al. Structure of the angiotensin I-converting enzyme gene: Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem. 1991 ; 266: 15377-15383
6. Mattei MG, Hubert C, Alhenc-Gelas F. Angiotensin converting enzyme is on chromosome 17. Cytogenet Cell Genet. 1989 ; 51: 1041-1045
7. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 ; 86: 1343-1346
8. Naresh VV, Reddy AL, Sivaramkrishna G. Angiotensin converting enzyme gene polymorphism in type 2 diabetics and nephropathy. Indian J Nephrol. 2010 ; 20: 119
9. Khan MK, Parimala N, Ishaq M. ACE I/D gene polymorphism in diabetic nephropathy: Clinical implications. J Med Allied Sci. 2011 ; 1: 42-45
10. Haque SF, Ahmad M, Khan AU. Angiotensin converting enzyme insertion/deletion gene polymorphism and genomic sequence in diabetic nephropathy. Biomed Res. 2011 ; 22: 173-177
11. Viswanathan V, Snehlatha B, Ramachandram A. Diabetic nephropathy - strategy of management. Int J Diab Dev Countries. 2000 ; 20: 45-48
12. Jacobsen PK. Preventing end stage renal disease in diabetic patients - genetic aspect (part 1). J Renin Angiotensin Aldosterone Syst. 2005 ; 6: 1-14
13. So WY, Ma RC, Ozaki R, et al. Angiotensin-converting enzyme (ACE) inhibition in type 2 diabetic patients: Interaction with ACE insertion/deletion polymorphism. Kidney Int. 2006 ; 69: 1438-1443
14. Baier LJ, Sacchettini JC, Knowler WC, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995 ; 95: 1281-1287
15. Agren JJ, Vidgren HM, Valve RS, et al. Postprandial response of individual fatty acids in subjects homozygous for the threonine or alanine encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr. 2001 ; 73: 31-35
16. Carlsson M, Orho-Melander M, Hedenbro J, et al. The T54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metab. 2000 ; 85: 2801-2804
17. Georgopoulos A, Aras O, Tsai MY. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in T2D. J Clin Endocrinol Metab. 2000 ; 85: 3155-3160
18. Weiss EP, Brown MD, Shuldiner AR, et al. Fatty acid binding protein-2 gene variants an insulin resistance: Gene and gene-environment interaction effects. Physiol Genomics. 2002 ; 10: 145-157
19. Pratley RE, Baier L, Pan DA, et al. Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res. 2000 ; 41: 2002-2008
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18: 499-502
21. Molecular cloning: A laboratory manual. 2 nd ed.New York: Cold Spring Harbor Laboratory Press, 1989, pp.9.14-9.19. Sambrook J Frisch EF Maniatis T, ed. New York: Cold Spring Harbor Laboratory Press ; 1989: 9.14-9.19.
22. Dalal AB, Tewari D, Tewari S, et al. Association of coronary artery disease with polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase gene. Indian Heart J. 2006 ; 58: 330-335
23. Yamada K, Yuan X, Ishiyama S, et al. Association between Ala54Thr substitution of the fatty acid binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 1997 ; 40: 706-710
24. Bonnet F, Patel S, Laville M, et al. Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care. 2008 ; 31: 789-794
25. Kajantie E, Rautanen A, Kare J, et al. The effects of the ACE gene polymorphism on glucose tolerance and insulin secretion in elderly people are modified by birth weight. J Clin Endocrinol Metab. 2004 ; 89: 5738-5741
26. Daimon M, Oizumi T, Saitoh T, et al. The D allele of the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for T2D in a population-based Japanese sample. Endocrine J. 2003 ; 50: 393-398
27. Bhavani BA, Padma T, Sastry BKS, et al. The insertion I/deletion D polymorphism of angiotensin-converting enzyme (ACE) gene increase the susceptibility to hypertension and/or diabetes. Int J Hum Genet. 2005 ; 5: 247-252
28. Hsieh MC, Lin SR, Hsieh TJ, et al. Increased frequency of angiotensin converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant. 2000 ; 15: 1008-1013
29. Nikzamir A, Nakhjavani M, Golmohammadi T, et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and ACE activity in type 2 diabetic patients. Acta Medica Iranica. 2008 ; 46: 277-282
30. Jayapalan JJ, Muniandy S, Chan SP. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J Hum Genet. 2010 ; 16: 78-86
31. Arfa I, Abid A, Nouira S, et al. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst. 2008 ; 9: 32-36
32. Stephens JW, Dhamrait SS, Caslake MJ, et al. The D allele of the ace I/D common gene variant is associated with T2D mellitus in Caucasian subjects. Mol Genet Metab. 2005 ; 84: 83-89
33. Degirmenci I, Kebapci N, Basaran A, et al. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Int J Clin Pract. 2005 ; 59: 1137-1142
34. Grammer TB, Renner W, Von Karger S, et al. The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study). Mol Genet Metab. 2006 ; 88: 378-383
35. Lee YJ, Tsai JCR. ACE gene insertion/deletion polymorphism associated with 1998. World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care. 2002 ; 25: 1002-1008
36. Vimaleswaran KS, Radha V, Mohan V. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism. 2006 ; 55: 1222-1226
37. Tahvanainen E, Molin M, Vainio S, et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis. 2000 ; 152: 317-325
38. Kim CH, Yun SK, Byun DW, et al. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia but not with intestinal fatty acid absorption in Korean men. Metabolism. 2001 ; 50: 473-476